STOCK TITAN

[8-K] Invitation Homes Inc. Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

Thermo Fisher Scientific (TMO) filed an 8-K announcing a planned CFO transition.

Senior Vice President & Chief Financial Officer Stephen Williamson will retire effective March 31 2026. To provide continuity, the board has appointed James R. Meyer (age 46), currently Vice President, Financial Operations, to become Senior Vice President & CFO effective March 1 2026. Meyer joined the company in 2009 and has held progressively senior finance roles, including VP of Finance, Customer Channels (2020-2022), before assuming his present post in January 2023; he previously worked at PwC.

No financial results, guidance, debt transactions or other material events were disclosed. The orderly, internally sourced succession suggests minimal operational disruption, although leadership change can introduce short-term uncertainty. Compensation or severance terms were not included in this filing.

Thermo Fisher Scientific (TMO) ha presentato un modulo 8-K annunciando una transizione pianificata del CFO.

Il Senior Vice President e Chief Financial Officer Stephen Williamson andrà in pensione a partire dal 31 marzo 2026. Per garantire continuità, il consiglio ha nominato James R. Meyer (46 anni), attualmente Vice President delle Operazioni Finanziarie, come nuovo Senior Vice President e CFO a partire dal 1 marzo 2026. Meyer è entrato in azienda nel 2009 e ha ricoperto ruoli finanziari via via più senior, incluso VP Finance, Customer Channels (2020-2022), prima di assumere l'attuale incarico nel gennaio 2023; in precedenza ha lavorato presso PwC.

Non sono stati comunicati risultati finanziari, previsioni, operazioni sul debito o altri eventi rilevanti. La successione ordinata e interna suggerisce un impatto operativo minimo, anche se un cambio di leadership può generare incertezza a breve termine. Nel documento non sono stati inclusi dettagli su compensi o indennità di fine rapporto.

Thermo Fisher Scientific (TMO) presentó un formulario 8-K anunciando una transición planificada en el puesto de CFO.

El Vicepresidente Senior y Director Financiero Stephen Williamson se retirará a partir del 31 de marzo de 2026. Para asegurar continuidad, la junta ha designado a James R. Meyer (46 años), actualmente Vicepresidente de Operaciones Financieras, como nuevo Vicepresidente Senior y CFO a partir del 1 de marzo de 2026. Meyer se unió a la empresa en 2009 y ha ocupado cargos financieros de mayor responsabilidad, incluyendo VP de Finanzas, Canales de Clientes (2020-2022), antes de asumir su puesto actual en enero de 2023; anteriormente trabajó en PwC.

No se divulgaron resultados financieros, pronósticos, transacciones de deuda u otros eventos relevantes. La sucesión ordenada y de origen interno sugiere una mínima interrupción operativa, aunque un cambio de liderazgo puede generar incertidumbre a corto plazo. No se incluyeron términos de compensación o indemnización en esta presentación.

Thermo Fisher Scientific (TMO)는 CFO 교체 계획을 알리는 8-K 보고서를 제출했습니다.

수석 부사장 겸 최고재무책임자(Senior Vice President & CFO) Stephen Williamson은 2026년 3월 31일부로 은퇴할 예정입니다. 이사회는 연속성을 위해 현재 재무운영 부사장인 James R. Meyer(46세)를 2026년 3월 1일부로 수석 부사장 겸 CFO로 임명했습니다. Meyer는 2009년 회사에 입사했으며, 고객 채널 재무 부사장(VP of Finance, Customer Channels, 2020-2022)을 포함해 점차 고위 재무직을 맡아왔으며, 2023년 1월부터 현재 직책을 수행하고 있습니다. 이전에는 PwC에서 근무했습니다.

재무 실적, 가이던스, 부채 거래 또는 기타 중요한 사건은 공개되지 않았습니다. 내부에서 원활하게 이루어진 승계는 운영상의 혼란이 최소화될 것으로 보이나, 리더십 교체는 단기적인 불확실성을 초래할 수 있습니다. 보상이나 퇴직금 조건은 이번 보고서에 포함되지 않았습니다.

Thermo Fisher Scientific (TMO) a déposé un formulaire 8-K annonçant une transition prévue au poste de CFO.

Le Senior Vice-Président et Directeur Financier Stephen Williamson prendra sa retraite à compter du 31 mars 2026. Afin d’assurer la continuité, le conseil d’administration a nommé James R. Meyer (46 ans), actuellement Vice-Président des Opérations Financières, au poste de Senior Vice-Président et CFO à compter du 1er mars 2026. Meyer a rejoint l’entreprise en 2009 et a occupé des postes financiers de plus en plus importants, notamment VP Finance, Customer Channels (2020-2022), avant de prendre son poste actuel en janvier 2023 ; il a auparavant travaillé chez PwC.

Aucun résultat financier, prévision, opération de dette ou autre événement important n’a été divulgué. Cette succession interne et ordonnée suggère une perturbation opérationnelle minimale, bien qu’un changement de direction puisse engendrer une incertitude à court terme. Les conditions de rémunération ou d’indemnités n’ont pas été incluses dans ce dépôt.

Thermo Fisher Scientific (TMO) hat ein 8-K Formular eingereicht, in dem ein geplanter CFO-Wechsel angekündigt wird.

Der Senior Vice President und Chief Financial Officer Stephen Williamson wird zum 31. März 2026 in den Ruhestand treten. Um Kontinuität zu gewährleisten, hat der Vorstand James R. Meyer (46 Jahre), derzeit Vice President Financial Operations, zum Senior Vice President und CFO mit Wirkung zum 1. März 2026 ernannt. Meyer ist seit 2009 im Unternehmen und hatte zunehmend verantwortungsvollere Finanzpositionen inne, darunter VP Finance, Customer Channels (2020-2022), bevor er im Januar 2023 seine aktuelle Position übernahm; zuvor arbeitete er bei PwC.

Es wurden keine Finanzergebnisse, Prognosen, Schuldentransaktionen oder andere wesentliche Ereignisse bekannt gegeben. Die geordnete, interne Nachfolge deutet auf minimale operative Störungen hin, obwohl ein Führungswechsel kurzfristige Unsicherheiten mit sich bringen kann. Vergütungs- oder Abfindungsbedingungen wurden in dieser Meldung nicht genannt.

Positive
  • Orderly transition: nine-month lead time and internal promotion should ensure continuity in financial leadership.
  • Experienced successor: James R. Meyer has 16 years at TMO across multiple finance functions, lowering execution risk.
Negative
  • CFO departure introduces potential short-term uncertainty until the market assesses Meyer’s performance.
  • Lack of financial details: filing provides no insight into compensation arrangements or strategic changes, leaving open questions for investors.

Insights

TL;DR: Internal successor limits risk; CFO exit unlikely to alter near-term financial outlook.

The eight-month notice period and one-month overlap give investors comfort that reporting cycles and capital-allocation plans should proceed uninterrupted. Meyer’s 16-year tenure means familiarity with Thermo Fisher’s M&A-driven growth model and integration processes, reducing execution risk. Because no revisions to guidance or strategy were mentioned, I classify the market impact as neutral unless further disclosures surface regarding compensation or strategic shifts.

TL;DR: Smooth succession aligns with governance best practices; no red flags detected.

Thermo Fisher adheres to governance norms by announcing the CFO retirement nine months in advance and appointing an experienced internal candidate. The board demonstrates succession planning depth, avoiding a disruptive external search. Absence of any mention of disputes, investigations, or abrupt departures mitigates concern. Nevertheless, investors should monitor upcoming proxy materials for details on Meyer’s compensation package and any post-retirement consulting role for Williamson.

Thermo Fisher Scientific (TMO) ha presentato un modulo 8-K annunciando una transizione pianificata del CFO.

Il Senior Vice President e Chief Financial Officer Stephen Williamson andrà in pensione a partire dal 31 marzo 2026. Per garantire continuità, il consiglio ha nominato James R. Meyer (46 anni), attualmente Vice President delle Operazioni Finanziarie, come nuovo Senior Vice President e CFO a partire dal 1 marzo 2026. Meyer è entrato in azienda nel 2009 e ha ricoperto ruoli finanziari via via più senior, incluso VP Finance, Customer Channels (2020-2022), prima di assumere l'attuale incarico nel gennaio 2023; in precedenza ha lavorato presso PwC.

Non sono stati comunicati risultati finanziari, previsioni, operazioni sul debito o altri eventi rilevanti. La successione ordinata e interna suggerisce un impatto operativo minimo, anche se un cambio di leadership può generare incertezza a breve termine. Nel documento non sono stati inclusi dettagli su compensi o indennità di fine rapporto.

Thermo Fisher Scientific (TMO) presentó un formulario 8-K anunciando una transición planificada en el puesto de CFO.

El Vicepresidente Senior y Director Financiero Stephen Williamson se retirará a partir del 31 de marzo de 2026. Para asegurar continuidad, la junta ha designado a James R. Meyer (46 años), actualmente Vicepresidente de Operaciones Financieras, como nuevo Vicepresidente Senior y CFO a partir del 1 de marzo de 2026. Meyer se unió a la empresa en 2009 y ha ocupado cargos financieros de mayor responsabilidad, incluyendo VP de Finanzas, Canales de Clientes (2020-2022), antes de asumir su puesto actual en enero de 2023; anteriormente trabajó en PwC.

No se divulgaron resultados financieros, pronósticos, transacciones de deuda u otros eventos relevantes. La sucesión ordenada y de origen interno sugiere una mínima interrupción operativa, aunque un cambio de liderazgo puede generar incertidumbre a corto plazo. No se incluyeron términos de compensación o indemnización en esta presentación.

Thermo Fisher Scientific (TMO)는 CFO 교체 계획을 알리는 8-K 보고서를 제출했습니다.

수석 부사장 겸 최고재무책임자(Senior Vice President & CFO) Stephen Williamson은 2026년 3월 31일부로 은퇴할 예정입니다. 이사회는 연속성을 위해 현재 재무운영 부사장인 James R. Meyer(46세)를 2026년 3월 1일부로 수석 부사장 겸 CFO로 임명했습니다. Meyer는 2009년 회사에 입사했으며, 고객 채널 재무 부사장(VP of Finance, Customer Channels, 2020-2022)을 포함해 점차 고위 재무직을 맡아왔으며, 2023년 1월부터 현재 직책을 수행하고 있습니다. 이전에는 PwC에서 근무했습니다.

재무 실적, 가이던스, 부채 거래 또는 기타 중요한 사건은 공개되지 않았습니다. 내부에서 원활하게 이루어진 승계는 운영상의 혼란이 최소화될 것으로 보이나, 리더십 교체는 단기적인 불확실성을 초래할 수 있습니다. 보상이나 퇴직금 조건은 이번 보고서에 포함되지 않았습니다.

Thermo Fisher Scientific (TMO) a déposé un formulaire 8-K annonçant une transition prévue au poste de CFO.

Le Senior Vice-Président et Directeur Financier Stephen Williamson prendra sa retraite à compter du 31 mars 2026. Afin d’assurer la continuité, le conseil d’administration a nommé James R. Meyer (46 ans), actuellement Vice-Président des Opérations Financières, au poste de Senior Vice-Président et CFO à compter du 1er mars 2026. Meyer a rejoint l’entreprise en 2009 et a occupé des postes financiers de plus en plus importants, notamment VP Finance, Customer Channels (2020-2022), avant de prendre son poste actuel en janvier 2023 ; il a auparavant travaillé chez PwC.

Aucun résultat financier, prévision, opération de dette ou autre événement important n’a été divulgué. Cette succession interne et ordonnée suggère une perturbation opérationnelle minimale, bien qu’un changement de direction puisse engendrer une incertitude à court terme. Les conditions de rémunération ou d’indemnités n’ont pas été incluses dans ce dépôt.

Thermo Fisher Scientific (TMO) hat ein 8-K Formular eingereicht, in dem ein geplanter CFO-Wechsel angekündigt wird.

Der Senior Vice President und Chief Financial Officer Stephen Williamson wird zum 31. März 2026 in den Ruhestand treten. Um Kontinuität zu gewährleisten, hat der Vorstand James R. Meyer (46 Jahre), derzeit Vice President Financial Operations, zum Senior Vice President und CFO mit Wirkung zum 1. März 2026 ernannt. Meyer ist seit 2009 im Unternehmen und hatte zunehmend verantwortungsvollere Finanzpositionen inne, darunter VP Finance, Customer Channels (2020-2022), bevor er im Januar 2023 seine aktuelle Position übernahm; zuvor arbeitete er bei PwC.

Es wurden keine Finanzergebnisse, Prognosen, Schuldentransaktionen oder andere wesentliche Ereignisse bekannt gegeben. Die geordnete, interne Nachfolge deutet auf minimale operative Störungen hin, obwohl ein Führungswechsel kurzfristige Unsicherheiten mit sich bringen kann. Vergütungs- oder Abfindungsbedingungen wurden in dieser Meldung nicht genannt.

false 0001687229 0001687229 2025-07-20 2025-07-20
 
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

Form 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): July 20, 2025

 

 

Invitation Homes Inc.

(Exact Name of Registrant as Specified in its charter)

 

 

 

Maryland   001-38004   90-0939055

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

5420 LBJ Freeway, Suite 600

Dallas, Texas 75240

(Address of principal executive offices, including zip code)

(972) 421-3600

(Registrant’s telephone number, including area code)

N/A

(Former Name or Former Address, if Changed Since Last Report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of Each Class

 

Trading

Symbol(s)

 

Name of Each Exchange

on Which Registered

Common stock, $0.01 par value   INVH   New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2):

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 
 


Item 5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers;

Compensatory Arrangements of Certain Officers.

On July 20, 2025, Charles D. Young resigned as the President of Invitation Homes Inc. (the “Company”), effective as of September 1, 2025. Dallas B. Tanner, the Company’s Chief Executive Officer will assume the responsibilities of the President. Biographical and other information regarding Mr. Tanner is set forth in the Companys definitive proxy statement for its 2025 Annual Meeting of Stockholders, filed with the Securities and Exchange Commission on April 3, 2025, and such information is incorporated by reference herein. The company has not entered into any new compensatory arrangements with Mr. Tanner in connection with his assumption of the role of President.

Mr. Young is leaving the Company to pursue other opportunities and his resignation is not the result of any disagreement with the Company on any matter relating to its strategy, operations, performance, policies, practices or otherwise.


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

INVITATION HOMES INC.
By:  

/s/ Mark A. Solls

  Name:   Mark A. Solls
  Title:  

Executive Vice President, Secretary

and Chief Legal Officer

Date: July 23, 2025

FAQ

When will Thermo Fisher Scientific's current CFO retire?

Stephen Williamson will retire effective March 31 2026.

Who has been appointed as the next CFO of TMO?

The board named James R. Meyer, currently VP, Financial Operations, to become CFO effective March 1 2026.

Does the 8-K include any financial results or guidance updates?

No, the filing is limited to the CFO succession and contains no earnings, revenue, or guidance information.

What is James R. Meyer’s background at Thermo Fisher?

Meyer joined in 2009, held various finance roles, was VP of Finance, Customer Channels (2020-2022), and became VP, Financial Operations in 2023.

Is there any information on Stephen Williamson’s severance or consulting role?

The 8-K does not disclose compensation, severance, or post-retirement arrangements.
Invitation Homes

NYSE:INVH

INVH Rankings

INVH Latest News

INVH Stock Data

19.53B
610.61M
0.37%
101.71%
2.27%
REIT - Residential
Real Estate Operators (no Developers) & Lessors
Link
United States
DALLAS